Zaloguj się

Gotowe bibliografie tematyczne / Disease prevention / Książki

Książki na temat „Disease prevention”

Kliknij ten link, aby zobaczyć inne rodzaje publikacji na ten temat: Disease prevention.

Autor: Grafiati

Data publikacji: 4 czerwca 2021

Data aktualizacji: 29 lipca 2024

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Sprawdź 50 najlepszych książek naukowych na temat „Disease prevention”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Przeglądaj książki z różnych dziedzin i twórz odpowiednie bibliografie.

1

Stang, Lucas. Disease prevention. Santa Cruz, Calif: ETR Associates, 1994.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

2

Wood, David. Cardiovascular disease prevention. London: Mosby, 2004.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

3

Washington (State). Dept. of Health., red. Chronic disease prevention. Olympia, Wash: The Department, 1994.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

4

S, Garewal Harinder, red. Antioxidants and disease prevention. Boca Raton: CRC Press, 1997.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

5

Allman, Toney. Nutrition and Disease Prevention. New York: Infobase Pub., 2010.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

6

G, Yanowitz Frank, red. Coronary heart disease prevention. New York: Dekker, 1992.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

7

Allman, Toney. Nutrition and disease prevention. New York: Chelsea House, 2010.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

8

H, Friedlaender Mitchell, i Alta California Eye Research Foundation., red. Prevention of eye disease. New York, NY: Mary Ann Liebert Inc., 1988.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

9

Warner, Hudson T., red. Clinical preventive medicine: Health promotion and disease prevention. Boston: Little, Brown, 1988.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

10

J, Murray John, red. The Prevention of dental disease. Wyd. 2. Oxford: Oxford University Press, 1989.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

11

Yamamoto, Sho L. Periodontal disease: Symptoms, treatment, and prevention. Hauppauge, N.Y: Nova Science, 2010.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

12

Kaplan, Robert M., i Michael H. Criqui, red. Behavioral Epidemiology and Disease Prevention. Boston, MA: Springer US, 1985. http://dx.doi.org/10.1007/978-1-4684-7929-4.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

13

United States. Public Health Service. Office of the Surgeon General, red. Exercise and heart disease prevention. [Washington, D.C.?]: Dept. of Health and Human Services, 1987.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

14

S, Ockene Ira, i Ockene Judith K, red. Prevention of coronary heart disease. Boston: Little, Brown, 1992.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

15

A, Golper Thomas, i Venkat Raman G, red. Renal disease: Prevention and treatment. London: Chapman & Hall Medical, 1998.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

16

Roehrig, Karla L. Risk factors and disease prevention. Columbus, Ohio (456 Clinic Dr., Columbus 43210): Dept. of Family Medicine, College of Medicine, Ohio State University, 1985.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

17

Authority, Newcastle Health, red. Coronary heart disease prevention policy. Newcastle upon Tyne: Newcastle Health Authority, 1988.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

18

Takayuki, Shibamoto, Terao Junji, Osawa Toshihiko, American Chemical Society. Division of Agricultural and Food Chemistry. i American Chemical Society Meeting, red. Functional foods for disease prevention. Washington, DC: American Chemical Society, 1998.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

19

S Mario Durrant DVM, Jane Fishman Leon, DVM Cody W. Faerber DVM. Canine: Medicine and Disease Prevention. Preston, Idaho: Animal Health Publications, 2004.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

20

NATO Advanced Research Workshop on Behavioral Epidemiology and Disease Prevention (1983 Bellagio Study and Conference Center). Behavioral epidemiology and disease prevention. New York: Plenum, 1985.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

21

J, Murray John, Nunn June H i Steele J. G, red. The prevention of oral disease. Wyd. 4. Oxford: Oxford University Press, 2003.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

22

J, Murray John, red. The prevention of oral disease. Wyd. 3. Oxford: Oxford University Press, 1995.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

23

Galle, P. R., W. E. Schmidt, G. Gerken i B. Wiedenmann, red. Disease Progression and Disease Prevention in Hepatology and Gastroenterology. Dordrecht: Springer Netherlands, 2006. http://dx.doi.org/10.1007/1-4020-5224-3.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

24

Muir, Gray J. A., red. Prevention of disease in the elderly. Edinburgh: Churchill Livingstone, 1985.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

25

Martin, Seth S., red. Precision Medicine in Cardiovascular Disease Prevention. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-75055-8.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

26

Wilkinson, Michael J., Michael S. Garshick i Pam R. Taub, red. Prevention and Treatment of Cardiovascular Disease. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-78177-4.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

27

Farmer, Nicole M., i Andres Victor Ardisson Korat. Cooking for Health and Disease Prevention. Boca Raton: CRC Press, 2022. http://dx.doi.org/10.1201/b22377.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

28

Kelishadi, Roya, red. Primordial Prevention of Non Communicable Disease. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-10616-4.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

29

Disease Prevention. Perfection Learning, 2005.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

30

Malvitz. Oral Health Promotion & Disease Prevention: Disease Prevention. W B Saunders Co, 1996.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

31

Disease Prevention Cookbook. American Diabetes Association, 2005.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

32

Sugano, Michihiro. Soy in Health and Disease Prevention (Nutrition and Disease Preventio). CRC, 2005.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

33

Loan, Denis Van. Coronary Heart Disease: Heart Disease Prevention. Independently Published, 2018.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

34

Bafadhel, Mona. Prevention of respiratory disease. Redaktorzy Patrick Davey i David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0344.

Pełny tekst źródła

Streszczenie:

The prevention of disease at a population health level rather than an individual health level is aimed at reducing causes of ‘preventable’ death and, under the auspices of public health and epidemiology, is an integral part of primary, secondary, and tertiary care. Classification of death is usually according to the type of primary disease or injury. However, there are a number of recognized risk factors for death, and modifications in behaviour or risk factors can substantially reduce preventable causes of death and the associated healthcare and economic burden of chronic disease management. According to the WHO, hundreds of millions of people from infancy to old age suffer from preventable chronic respiratory diseases, there are over four million deaths annually from preventable respiratory diseases, and common respiratory disorders (e.g. lower respiratory tract infections, chronic obstructive pulmonary disease, lung cancer, and tuberculosis) account for approximately 20% of all deaths worldwide. This chapter discusses the prevention of respiratory disease, covering diseases associated with smoking (one of the biggest risk factors associated with preventable deaths), air pollution, and other lifestyle factors associated with respiratory disease; changes in legislation concerning smoking and work-related respiratory disease; and, finally, the prevention of respiratory diseases through the use of immunization and screening tools.

Style APA, Harvard, Vancouver, ISO itp.

35

Banerjee, Amitava, i Kaleab Asrress. Prevention of cardiovascular disease. Redaktorzy Patrick Davey i David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0343.

Pełny tekst źródła

Streszczenie:

The global scale of the cardiovascular disease epidemic is unquestionable, with cardiovascular disease causing a greater burden of mortality and morbidity than any other disease, regardless of country or population. With demographic change and ageing populations, the prevalence of cardiovascular disease and its risk factors is set to increase. The commonest cardiovascular diseases are atherosclerotic, affecting all arterial territories. The ‘burden of disease’ approach has highlighted the fact that cardiovascular disease and non-communicable diseases are not simply diseases of affluence but affect people of all countries, with enormous costs in terms of public health, healthcare, and overall economies. Coronary artery disease is the leading cause of mortality in all regions of the world apart from sub-Saharan Africa, followed by cerebrovascular disease. It should be noted, however, that there has been a major decline in cardiovascular disease mortality in Western Europe, the US, and Japan over the past 40 years. There are multiple factors underlying these favourable trends but understanding the epidemiology and characterizing individual risk factors for cardiovascular disease has been central in formulating preventive and treatment strategies. The INTERHEART study showed that 90% of cardiovascular risk can be explained by nine easily identifiable risk factors; an awareness of these, and the discovery of novel factors, will continue to serve in the fight to reduce the burden of cardiovascular disease. Geoffrey Rose first championed population-wide approaches versus strategies which target only high-risk individuals. Prevention aims to ‘catch the disease’ upstream, therefore delaying, reducing, or eliminating the risk of coronary artery disease. Surrogate markers for coronary artery disease have emerged in efforts to detect disease at earlier stages, and in order to better understand the pathophysiology. For example, coronary artery calcium scoring is emerging as a marker of future risk of coronary artery disease. Risk stratification scores are increasingly used as tools to individualize a person’s future risk of coronary artery disease in order to better target treatment and prevention strategies.

Style APA, Harvard, Vancouver, ISO itp.

36

Fessenden, Ronald. Disease Prevention Handbook: Strategies for Preventing Disease and Maintaining Good Health. Independently Published, 2017.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

37

Chakera, Aron, William G. Herrington i Christopher A. O’Callaghan. Prevention of kidney disease. Redaktorzy Patrick Davey i David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0345.

Pełny tekst źródła

Streszczenie:

A number of factors are known to predispose to renal disease, such as diabetes mellitus, hypertension, and exposure to certain drugs or substances (e.g. mercury and other heavy metals). In people who are at risk for these reasons, renal function should be regularly monitored as part of routine care. Kidney diseases are identified by elevations in the serum creatinine; the presence in the urine of blood, protein, or elevated levels of certain electrolytes; or evidence of anatomical abnormalities. Due to the large functional reserve of the kidneys, symptoms of impaired renal function usually occur late in the course of disease, highlighting the importance of early detection and, where available, the use of ameliorating therapies.

Style APA, Harvard, Vancouver, ISO itp.

38

Keshav, Satish, i Alexandra Kent. Prevention of gastrointestinal disease. Redaktorzy Patrick Davey i David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0346.

Pełny tekst źródła

Streszczenie:

Disease prevention is usually directed where there is considerable morbidity or mortality, and etiological factors that can be controlled, treated, or reduced. The greatest morbidity and mortality from gastrointestinal disease is related to infectious diarrhoea and gastrointestinal cancer, both of which can be prevented. Smoking has been closely associated with oesophageal, gastric, and liver cancer and also has a significant effect in inflammatory bowel disease. In addition, alcohol consumption and viral hepatitis are preventable causes of liver disease, liver failure, and hepatic cancer. This chapter addresses the prevention of gastrointestinal disease, focusing on alcohol, smoking, peptic ulcer disease, colorectal cancer, oesophageal adenocarcinoma, hepatitis B, hepatitis C, non-alcoholic fatty liver disease, and gastrointestinal infection.

Style APA, Harvard, Vancouver, ISO itp.

39

Morrison, Karen. Prevention of neurological disease. Redaktorzy Patrick Davey i David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0347.

Pełny tekst źródła

Streszczenie:

Neurological disease is very common. It is estimated that one-third of consultations with general practitioners involve neurological complaints, and neurological disorders are present in one-third of patients admitted to hospital. In considering how to reduce the incidence of neurological disease, one must take into account the feasibility of prevention, and the overall morbidity caused by the disease. In stroke, which is very common, interventions which reduce incidence by a small percentage have the potential to have a large impact on a population basis. A disorder such as migraine, while not life-limiting, accounts for significant morbidity and time off work (one study suggests that there are the equivalent of 112 million bedridden days per year due to migraine alone), so, again, interventions that reduce the frequency of episodes even by a small percentage can have great overall impact. This chapter discusses the major categories of neurological disease based on pathogenesis, and current and future approaches to prevention.

Style APA, Harvard, Vancouver, ISO itp.

40

Morrison, Karen. Prevention of cerebrovascular disease. Redaktorzy Patrick Davey i David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0348.

Pełny tekst źródła

Streszczenie:

Stroke is the main cause of neurological morbidity in adults and the third most common cause of death worldwide after ischaemic heart disease and cancer (all forms combined). It is more common in older people, with three-quarters of strokes occurring in people over 65 years of age, and estimates are that overall stroke morbidity will double by the early 2020s. The worldwide figure of increasing incidence of stroke detection masks the fact that mortality from stroke has actually been falling in developed countries since the latter half of the twentieth century while the mortality has continued to rise in China, Asia, and eastern Europe. This chapter discusses prevention of cerebrovascular disease, and includes strategies to reduce the risk of thromboembolic stroke and cerebral haemorrhage.

Style APA, Harvard, Vancouver, ISO itp.

41

Isaranuwatchai, Wanrudee, Rachel A. Archer, Yot Teerawattananon i Anthony Culyer, red. Non-communicable Disease Prevention. Open Book Publishers, 2019. http://dx.doi.org/10.11647/obp.0195.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

42

Holland, Walter W., i Susie Stewart. Screening in Disease Prevention. CRC Press, 2018. http://dx.doi.org/10.1201/9781315377537.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

43

Foundation, Life Extension. Disease Prevention and Treatment. Wyd. 4. Life Extension Media, 2003.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

44

Stein, Mary. Cardiovascular Disease: Evaluation & Prevention. Western Schools, 1990.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

45

Segala, Melanie. Disease Prevention and Treatment. Wyd. 3. Life Extension Media, 2000.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

46

Harber. Prevention Of Pulm Disease. Hanley & Belfus, 1991.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

47

S Sue Khuon Bs Ma. Disease Prevention and Longevity. Page Publishing, Inc., 2022.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

48

Evans, C. De Lacy. The Prevention Of Disease. Kessinger Publishing, LLC, 2005.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

49

(Editor), Michael Grundman, i Leon J. Thal (Editor), red. Prevention of Alzheimer's Disease. Martin Dunitz, 2000.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

50

S. Sue Khuon Bs Ma. Disease Prevention and Longevity. Page Publishing Inc., 2022.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!